Join Cooley at the 2016 BIO International Convention in San Francisco.
The BIO International Convention is the largest global event for the biotechnology industry, attracting over 15,000 biotechnology and pharma leaders while covering a wide range of life science and application areas.
Featured Cooley Panels:
Monday, June 6, 2016: 8:30 am - 3:45 pm
BIO Business Development Fundamentals Program - This program provides an intensive and comprehensive educational foundation regarding the core skills that are needed to be a successful licensing executive in the life sciences industry.
Ken Krisko is leading this class.
Tuesday, June 7, 2016: 9:10 am - 9:45 am
A Conversation with Bryan Roberts at the Digital Health Summer Summit during BIO - Wainwright Fishburn and Bryan Roberts, Partner, Venrock will discuss future opportunities and investment trends in digital health.
Wednesday, June 8, 2016: 10:45 am - 12 pm
Biotech Alliance Terms are [Not] Crazy - The economics of biopharma alliances have skyrocketed, with $150 billion in announced deal terms since 2012. Are these terms sustainable?
Barbara Kosacz is a featured panelist.
Wednesday, June 8, 2016: 1 pm - 2 pm
Successful Pharmaceutical Branding: Key Insights from the Business, Legal and Creative Process - This panel provides a broad overview of the role brands play in the increasingly competitive pharmaceutical marketplace. Our panelists will provide an overview of the changes taking place in the pharmaceutical marketplace, including the impact of biosimilars and the issues faced by pharmaceutical companies post patent expiration. We will describe the pharmaceutical branding process from the creative naming inception to approval of the brand at the FDA and US trademark office and conclude with best practices to achieve a successful pharmaceutical brand.
Janet Cullum, Co-Chair of BIO's IP Track, is a featured panelist.
Wednesday, June 8, 2016: 3:30 pm - 4:30 pm
Digital Health Investment: Active Investors Will Share Their 2016 Investment Thesis - Digital health funding continues to grow, with more than $8 billion invested over the last two years. With the proliferation of companies, investors are more discerning on the placement of new investments.
Wainwright Fishburn, Co-Chair of BIO's Digital Health Track for the third consecutive year, will lead the discussion.
Register for this event